MedTrace Logo

Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis

NCT02714283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90089

Last updated 2019-09-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to provide patients and their physicians with greater understanding of the risks and benefits of commonly used therapies for treatment of non-CF bronchiectasis

Conditions

Interventions

DRUG

inhaled corticosteroid therapy

We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies

DRUG

macrolide therapy

We will evaluate and compare the clinical effectiveness and safety of long-term inhaled corticosteroid and macrolide antimicrobial therapies

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • National Jewish Health

    collaborator OTHER

  • COPD Foundation

    collaborator OTHER

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Kevin L Winthrop, MD, MPH · Oregon Health and Science University

  • Emily Henkle, PhD, MPH · Oregon Health and Science University

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-28
Primary Completion
2018-06-30
Completion
2018-07-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02714283 on ClinicalTrials.gov